[en] Nitric oxide has been implicated in the regulation of enzyme activity, particularly the activity of metalloproteinases. Since the inducible form of the nitric oxide synthase (NOS2), is upregulated in Alzheimer's disease, we investigated the activity of two amyloid β degrading enzymes, IDE and neprilysin. In vitro we demonstrated that the activity of IDE was inhibited by *NO donor Sin-1, whereas activity of neprilysin remained unaffected. In vivo the activity of insulin-degrading enzyme was lowered in APP/PS1 mice, but not in APP/PS1/NOS2(-/-) mice. These data suggest that NOS2 upregulation impairs amyloid β degradation through negative regulation of IDE activity and thus loss of NOS2 activity will positively influence amyloid β clearance.
Disciplines :
Neurologie
Auteur, co-auteur :
Kummer, Markus P; Clinical Neurosciences Unit, Department of Neurology, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany
Hülsmann, Claudia; Clinical Neurosciences Unit, Department of Neurology, University of Bonn, 53105 Bonn, Germany
Hermes, Michael; Clinical Neurosciences Unit, Department of Neurology, University of Bonn, 53105 Bonn, Germany
Axt, Daisy; Clinical Neurosciences Unit, Department of Neurology, University of Bonn, 53105 Bonn, Germany
HENEKA, Michael ; Clinical Neurosciences Unit, Department of Neurology, University of Bonn, 53105 Bonn, Germany
Co-auteurs externes :
yes
Langue du document :
Anglais
Titre :
Nitric oxide decreases the enzymatic activity of insulin degrading enzyme in APP/PS1 mice.
Date de publication/diffusion :
mars 2012
Titre du périodique :
Journal of Neuroimmune Pharmacology
ISSN :
1557-1890
eISSN :
1557-1904
Maison d'édition :
Springer Science and Business Media LLC, Etats-Unis
This study was supported by a grant from the Deutsche Forschungsgemeinschaft (HE 3350/4-1,4-2) to MTH. M.P.Kummer.C.Hülsmann.M.Hermes.D.Axt. M. T. Heneka (*) Clinical Neurosciences Unit, Department of Neurology, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany e-mail: michael.heneka@ukb.uni-bonn.de
Bulloj A, Leal MC, Xu H, Castaño EM, Morelli L (2010) Insulindegrading enzyme sorting in exosomes: a secretory pathway for a key brain amyloid-beta degrading protease. J Alzheim Dis 19:79-95
Butterfield DA, Reed TT, Perluigi M, De Marco C, Coccia R, Keller JN, Markesbery WR, Sultana R (2007) Elevated levels of 3- nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease. Brain Res 1148:243-248 (Pubitemid 46602178)
Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DA (2003) Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 85:1394-1401 (Pubitemid 36702552)
Cordes CM, Bennett RG, Siford GL, Hamel FG (2009) Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation. Biochem Pharmacol 77:1064-1073
Crow JP, Ischiropoulos H (1996) [17] Detection and quantitation of nitrotyrosine residues in proteins: In vivo marker of peroxynitrite. In: Nitric oxide part B: physiological and pathological processes. Academic Press, pp 185-194 (Pubitemid 26295707)
Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 100:4162-4167 (Pubitemid 36418174)
Fernández-Vizarra P, Fernández AP, Castro-Blanco S, Encinas JM, Serrano J, Bentura ML, Muñoz P, Martínez-Murillo R, Rodrigo J (2004) Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease. Neurobiol Dis 15:287-305 (Pubitemid 38296760)
Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RA (1998) Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 18:8126-8132 (Pubitemid 28464991)
Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine-Aizawa Yet al (2000) Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6:143-150 (Pubitemid 30082357)
Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR (2001) Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17:157-165 (Pubitemid 32409891)
Kummer MP, Hermes M, Delekarte A, Hammerschmidt T, Kumar S, Terwel D, Walter J, Pape H-C, König S, Roeber S et al (2011) Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation. Neuron 71:833-844
Laubach VE, Shesely EG, Smithies O, Sherman PA (1995) Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci U S A 92:10688-10692
Lee SC, Zhao ML, Hirano A, Dickson DW (1999) Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques. J Neuropathol Exp Neurol 58:1163-1169 (Pubitemid 29519840)
Lüth HJ, Holzer M, Gärtner U, Staufenbiel M, Arendt T (2001) Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. Brain Res 913:57-67 (Pubitemid 32786931)
Lüth H-J, Münch G, Arendt T (2002) Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res 953:135-143 (Pubitemid 35217815)
Malito E, Hulse RE, Tang W-J (2008) Amyloid β-degrading cryptidases: insulin degrading enzyme, neprilysin, and presequence peptidase. Cell Mol Life Sci 65:2574-2585
Martin-Romero FJ, Gutiérrez-Martin Y, Henao F, Gutiérrez-Merino C (2004) Fluorescence measurements of steady state peroxynitrite production upon SIN-1 decomposition: NADH versus dihydrodichlorofluorescein and dihydrorhodamine 123. J Fluoresc 14:17-23
Nakamura T, Lipton SA (2009) Cell death: protein misfolding and neurodegenerative diseases. Apoptosis 14:455-468
Nikitovic D, Holmgren A (1996) S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J Biol Chem 271:19180-19185 (Pubitemid 26271582)
Pervin S, Singh R, Chaudhuri G (2001) Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1. Proc Natl Acad Sci U S A 98:3583-3588 (Pubitemid 32220888)
Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362:329-344
Radi R (2004) Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A 101:4003-4008 (Pubitemid 38405874)
Ralat LA, Ren M, Schilling AB, Tang W-J (2009) Protective role of Cys-178 against the inactivation and oligomerization of human insulin-degrading enzyme by oxidation and nitrosylation. J Biol Chem 284:34005-34018
Rodrigo J, Fernández-Vizarra P, Castro-Blanco S, Bentura ML, Nieto M, Gómez-Isla T, Martínez-Murillo R, MartInez A, Serrano J, Fernández AP (2004) Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice. Neuroscience 128:73-89 (Pubitemid 39140681)
Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17:2653-2657 (Pubitemid 27154998)
Song E-S, Juliano MA, Juliano L, Hersh LB (2003) Substrate activation of insulin-degrading enzyme (insulysin). A potential target for drug development. J Biol Chem 278:49789-49794 (Pubitemid 37548812)
Souza JM, Peluffo G, Radi R (2008) Protein tyrosine nitration-functional alteration or just a biomarker? Free Radic Biol Med 45:357-366
Stamler JS, Toone EJ, Lipton SA, Sucher NJ (1997) (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18:691-696
Tamboli IY, Barth E, Christian L, Siepmann M, Kumar S, Singh S, Tolksdorf K, Heneka MT, Lütjohann D, Wunderlich P et al (2010) Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulindegrading enzyme (IDE) secretion. J Biol Chem 285:37405-37414
Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E, Isobe C (1999) Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neurosci Lett 269:52-54 (Pubitemid 29305700)
Vodovotz Y, Lucia MS, Flanders KC, Chesler L, Xie QW, Smith TW, Weidner J, Mumford R, Webber R, Nathan C et al (1996) Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J Exp Med 184:1425-1433 (Pubitemid 26354698)
Wilcock DM, Lewis MR, Van Nostrand WE, Davis J, Previti ML, Gharkholonarehe N, Vitek MP, Colton CA (2008) Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2. J Neurosci 28:1537-1545 (Pubitemid 351287042)
